Graded elastic metasurface for enhanced energy harvesting

In elastic wave systems, combining the powerful concepts of resonance and spatial grading within structured surface arrays enable resonant metasurfaces to exhibit broadband wave trapping, mode conversion from surface (Rayleigh) waves to bulk (shear) waves, and spatial frequency selection. Devices built around these concepts allow for precise control of surface waves, often with structures that are subwavelength, and utilise Rainbow trapping that separates the signal spatially by frequency. Rainbow trapping yields large amplifications of displacement at the resonator positions where each frequency component accumulates. We investigate whether this amplification, and the associated control, can be used to create energy harvesting devices; the potential advantages and disadvantages of using graded resonant devices as energy harvesters is considered. We concentrate upon elastic plate models for which the A0 mode dominates, and take advantage of the large displacement amplitudes in graded resonant arrays of rods, to design innovative metasurfaces that trap waves for enhanced piezoelectric energy harvesting. Numerical simulation allows us to identify the advantages of such graded metasurface devices and quantify its efficiency, we also develop accurate models of the phenomena and extend our analysis to that of an elastic half-space and Rayleigh surface waves

Analytical solutions for Bloch waves in resonant phononic crystals: deep-subwavelength energy splitting and mode steering between topologically protected interfacial and edge states

We derive analytical solutions based on singular Green’s functions, which enable efficient computations of scattering simulations or Floquet–Bloch dispersion relations for waves propagating through an elastic plate, whose surface is patterned by periodic arrays of elastic beams. Our methodology is versatile and allows us to solve a range of problems regarding arrangements of multiple beams per primitive cell, over Bragg to deep-subwavelength scales; we cross-verify against finite element numerical simulations to gain further confidence in our approach, which relies upon the hypothesis of Euler–Bernoulli beam theory considerably simplifying continuity conditions such that each beam can be replaced by point forces and moments applied to the neutral plane of the plate. The representations of Green’s functions by Fourier series or Fourier transforms readily follows, yielding rapid and accurate analytical schemes. The accuracy and flexibility of our solutions are demonstrated by engineering topologically non-trivial states, from primitive cells with broken spatial symmetries, following the phononic analogue of the Quantum Valley Hall Effect. Topologically protected states are produced and coexist along: interfaces between adjoining chiral-mirrored bulk media, and edges between one such chiral bulk and the surrounding bare elastic plate, allowing topological circuits to be designed with robust waveguiding. Our topologically protected interfacial states correspond to zero-line modes, and our topological edgestates are produced in accordance with the bulk-edge correspondence. These topologically non-trivial states exist within near flexural resonances of the constituent beams of the phononic crystal and hence can be tuned into a deep-subwavelength regime

Fifteen years of XMM-Newton and Chandra monitoring of Sgr A*: Evidence for a recent increase in the bright flaring rate

We present a study of the X-ray flaring activity of Sgr A* during all the 150 XMM-Newton and Chandra observations pointed at the Milky Way center over the last 15 years. This includes the latest XMM-Newton and Chandra campaigns devoted to monitoring the closest approach of the very red Br-Gamma emitting object called G2. The entire dataset analysed extends from September 1999 through November 2014. We employed a Bayesian block analysis to investigate any possible variations in the characteristics (frequency, energetics, peak intensity, duration) of the flaring events that Sgr A* has exhibited since their discovery in 2001. We observe that the total bright-or-very bright flare luminosity of Sgr A* increased between 2013-2014 by a factor of 2-3 (~3.5 sigma significance). We also observe an increase (~99.9% significance) from 0.27+-0.04 to 2.5+-1.0 day^-1 of the bright-or-very bright flaring rate of Sgr A*, starting in late summer 2014, which happens to be about six months after G2's peri-center passage. This might indicate that clustering is a general property of bright flares and that it is associated with a stationary noise process producing flares not uniformly distributed in time (similar to what is observed in other quiescent black holes). If so, the variation in flaring properties would be revealed only now because of the increased monitoring frequency. Alternatively, this may be the first sign of an excess accretion activity induced by the close passage of G2. More observations are necessary to distinguish between these two hypotheses.Comment: Accepted for publication in MNRA

Total orthotopic small bowel transplantation in swine under FK 506

Previous experimental studies in rodents and in dogs have established the efficacy of FK 506 in controlling the immunologic events following small bowel or multivisceral transplantation.1–5 To complete the assessment of FK 506 in experimental small bowel transplantation, we present here our experience with the frequently used swine model

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System

BACKGROUND: The dopaminergic partial agonism of the so-called third-generation antipsychotics (TGAs; aripiprazole, brexpiprazole, cariprazine) is hypothesized to cause impulse control disorders (ICDs). Relevant warnings by the Food and Drug Administration (FDA) were posted on aripiprazole (2016) and brexpiprazole (2018). Our study investigated the FDA Adverse Event Reporting System and the pharmacodynamic CHEMBL database to further characterize TGA-induced ICDs. METHODS: We downloaded and pre-processed the FDA Adverse Event Reporting System up to December 2020. We adapted Bradford Hill criteria to assess each TGA's -and secondarily other antipsychotics'-causal role in inducing ICDs (pathological gambling, compulsive shopping, hyperphagia, hypersexuality), accounting for literature and disproportionality. ICD clinical features were analyzed, and their pathogenesis was investigated using receptor affinities. RESULTS: A total of 2708 reports of TGA-related ICDs were found, primarily recording aripiprazole (2545 reports, 94%) among the drugs, and gambling (2018 reports, 75%) among the events. Bradford-Hill criteria displayed evidence for a causal role of each TGA consistent across subpopulations and when correcting for biases. Significant disproportionalities also emerged for lurasidone with compulsive shopping, hyperphagia, and hypersexuality, and olanzapine and ziprasidone with hyperphagia. Time to onset varied between days and years, and positive dechallenge was observed in 20% of cases. Frequently, co-reported events were economic (50%), obsessive-compulsive (44%), and emotional conditions (34%). 5-Hydroxytryptamine receptor type 1a agonism emerged as an additional plausible pathogenetic mechanism. CONCLUSIONS: We detected an association between TGAs and ICDs and identified a new signal for lurasidone. ICD characteristics are behavior specific and may heavily impact on life. The role of 5-Hydroxytryptamine receptor type 1a agonism should be further explored

Ex vivo effect of vascular wall stromal cells secretome on enteric ganglia

BACKGROUND Mesenchymal stromal cell (MSC)-based therapy is currently under study to treat inflammatory bowel diseases. MSC bioactive products could represent a valid alternative to overcome issues associated with systemic whole-cell therapies. However, MSC anti-inflammatory mechanisms differ between rodents and humans, impairing the reliability of preclinical models. AIM To evaluate the effect of conditioned medium (CM) derived from porcine vascular wall MSCs (pVW-MSCs) on survival and differentiation of porcine and Guinea pig enteric ganglia exposed to lipopolysaccharide (LPS). METHODS Primary cultures of enteric ganglia were obtained by mechanic and enzymatic digestion of ileum resections from Guinea pigs (Cavia porcellus) (GPEG) and pigs (Suus scrofa) (PEG). pVW-MSCs were derived by enzymatic digestion from vascular wall resections of porcine aorta and tested by immunoflowcytometry for MSC immune profile. Enteric ganglia were treated with increasing concentrations of LPS, CM derived by pVW-MSCs or a combination of CM and LPS 1 \u3bcg/mL. Cell count and morphometric analysis of HuD positive neurons and glial fibrillary acidic protein positive glial cells were performed by immunofluorecent staining of cultured ganglia. RESULTS PEG showed a higher number of neurons compared to GPEG. Overall, CM exerted a protective role on LPS-treated enteric ganglia. CM in combination with LPS increased the number of glial cells per ganglion in both cultures evoking glial cells differentiation in porcine cultures. CONCLUSION These findings suggest an immunomodulating activity of pVW-MSCs mediators on the enteric nervous system in inflammatory conditions

Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation

This study examines the role played by cyclooxygenase (COX) isoforms (COX-1 and -2) in the regulation of colonic neuromuscular function in normal rats and after induction of colitis by 2,4-dinitrobenzenesulfonic acid (DNBS). The expression of COX-1 and COX-2 in the colonic neuromuscular layer was assessed by reverse transcription-polymerase chain reaction and immunohistochemistry. The effects of COX inhibitors on in vitro motility were evaluated by studying electrically induced and carbachol-induced contractions of the longitudinal muscle. Both COX isoforms were constitutively expressed in normal colon; COX-2 was up-regulated in the presence of colitis. In normal and inflamed colon, both COX isoforms were mainly localized in neurons of myenteric ganglia. In the normal colon, indomethacin (COX-1/COX-2 inhibitor), SC-560 [5-(4-chloro-phenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole] (COX-1 inhibitor), or DFU [5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone] (COX-2 inhibitor) enhanced atropine-sensitive electrically evoked contractions. The most prominent effects were observed with indomethacin or SC-560 plus DFU. In the inflamed colon, SC-560 lost its effect, whereas indomethacin and DFU maintained their enhancing actions. These results were more evident after blockade of noncholinergic pathways. In rats with colitis, in vivo treatment with superoxide dismutase or S-methylisothiourea (inhibitor of inducible nitric-oxide synthase) restored the enhancing motor effect of SC-560. COX inhibitors had no effect on carbachol-induced contractions in normal or DNBS-treated rats. In conclusion, in the normal colon, both COX isoforms act at the neuronal level to modulate the contractile activity driven by excitatory cholinergic pathways. In the presence of inflammation, COX-1 activity is hampered by oxidative stress, and COX-2 seems to play a predominant role in maintaining an inhibitory control of colonic neuromuscular function